Abstract: Aptamers against the glycosylated form of MUC1 are described, along with their use in treatment and diagnosis of conditions associated with elevated production of MUC1.
Type:
Grant
Filed:
May 2, 2007
Date of Patent:
October 18, 2011
Assignees:
The Open University, The University Health Network
Inventors:
Sotiris Missailidis, Jean Gariepy, Catia Sofia Matos Ferreira